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Abstract
Purpose To investigate clinical implications of FDG uptake
in the thyroid glands in patients with advanced breast
carcinoma by comparing metabolic and morphologic
patterns on positron emission tomography (PET)/computed
tomography (CT).
Methods The institutional review board waived the require-
ment for informed consent. A retrospective analysis was
performed in 146 women (mean age 54 years) with
advanced breast carcinoma who received systemic treatment.
All patients underwent PET-CT before and after treatment.
All PET-CT studies were reviewed in consensus by two
reviewers. Morphologic changes including volume and mean
parenchymal density of the thyroid glands were evaluated.
Maximum standardized uptake value (SUVmax) and total
lesion glycolysis (TLG) were determined to evaluate
metabolic changes. These parameters were compared between
patients with chronic thyroiditis who received thyroid
hormone replacement therapy and those who did not.
Results Of the 146 patients, 29 (20%) showed bilaterally
diffuse uptake in the thyroid glands on the baseline PET-CT
scan. The SUVmax showed a linear relationship with
volume (r=0.428, p=0.021) and the mean parenchymal
density (r=−0.385, p=0.039) of the thyroid glands. In 21 of
the 29 patients (72%) with hypothyroidism who received
thyroid hormone replacement therapy, the volume, mean
parenchymal density, SUVmax, and TLG of the thyroid
glands showed no significant changes. In contrast, 8 of the
29 patients (28%) who did not receive thyroid hormone
replacement therapy showed marked decreases in SUVmax
and TLG.
Conclusion Diffuse thyroid uptake on PET-CT represents
active inflammation caused by chronic thyroiditis in
patients with advanced breast carcinoma. Diffuse thyroid
uptake may also address the concern about subclinical
hypothyroidism which develops into overt disease during
follow-up.
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Introduction
Fluorine-18-fluorodeoxyglucose (FDG) positron emission
tomography/computed tomography (PET-CT) is a noninva-
sive whole-body imaging technique used to evaluate many
kinds of malignant tumors. The results of previous studies
suggest that incidental uptake in the thyroid glands is often
encountered in daily practice [1]. Some patterns of thyroid
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